Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 15, 188-198, March 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, J. A.
Right arrow Articles by Rusch, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, J. A.
Right arrow Articles by Rusch, H. P.

The Carcinogenicity of Compounds Related to 2-Acetylaminofluorene

II. Variations in the Bridges and the 2-Substituent* ,{dagger}

J. A. Miller, R. B. Sandin, E. C. Miller and H. P. Rusch

( McArdle Memorial Laboratory, Medical School, University of Wisconsin, Madison 6, Wis., and Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada)

1. The carcinogenic activities of fourteen compounds structurally related to 2-acetylaminofluorene and which differ principally in the nature of the bridges between the two aromatic rings have been determined in the rat. These compounds are the 2-acetylamino derivatives of 9-fluorenol, 9-fluorenone, phenanthrene, 9,10-dihydrophenanthrene, carbazole, pyrene, and dibenzothiophene; the 3-acetylamino derivatives of phenanthrene, carbazole, dibenzothiophene sulfone, and diphenylmethane; the 4-acetylamino derivatives of diphenylsulfide and biphenyl; and 1-acetylaminopyrene.
2. 2-Acetylaminofluorene induced high incidences of liver tumors in the males and of mammary gland tumors in the females and moderate incidences of tumors of the ear duct and small intestinal epithelium in both sexes.
3. A fluorene nucleus appears to be required for strong carcinogenic activity toward the liver. 2-Acetylamino-9-fluorenol and 2-acetylamino-9-fluorenone had weak activity; the other compounds were inactive.
4. A biphenyl nucleus is apparently necessary for carcinogenic activity toward the mammary gland. 4-Acetylaminobiphenyl was as active as 2-acetylaminofluorene, and a number of compounds with bridges in the 2, 2'-positions were also active.
5. The requirements for carcinogenicity toward the ear duct and intestinal epithelium were intermediate between those of the liver and mammary gland; in general, a tricyclic derivative was necessary.
6. 2-Acetylaminophenanthrene, in addition to inducing tumors of the mammary gland, ear duct, and intestinal epithelium, also had a moderate leukemogenic activity. When fed at higher levels, it induced a paralysis of the hind limbs.
7. 7-Fluoro-2-acetylaminofluorene was much more active toward the liver of both male and female rats than 2-acetylaminofluorene. The activity toward the other tissues was not enhanced by this fluoro-substitution.
8. In agreement with the work of others 2-nitro-, 2-amino-, and 2-dimethylaminofluorene were less active than 2-acetylaminofluorene at the usual sites. In addition, 2-nitrofluorene induced a high incidence of squamous-cell carcinomas of the forestomach.
9. On histological examination a high proportion of the tumors induced by each compound and at all sites were found to be malignant.
10. The syntheses of the following new compounds are described: 2-acetylaminocarbazole and 7-fluoro-2-acetylaminofluorene.

* This work was supported by grants-in-aid from the National Cancer Institute, United States Public Health Service (No. C355), from the American Cancer Society upon recommendation of the Committee on Growth of the National Research Council, and from the Alberta Branch of the Canadian Cancer Society and by institutional grants from the American Cancer Society (INSTR 71B) and the Alexander and Margaret Stewart Trust Fund.

{dagger} Paper 1 of this series is reference (39).

Received 12/ 1/54.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1955 by the American Association for Cancer Research.